HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuromuscular transmission is not impaired in axonal Guillain--Barré syndrome.

AbstractBACKGROUND:
Previous studies have shown that anti-GQ1b antibodies induce massive neuromuscular blocking. If anti-GM1 and -GD1a antibodies have similar effects on the neuromuscular junction (NMJ) in human limb muscles, this may explain selective motor involvement in axonal Guillain--Barré syndrome (GBS).
METHODS:
Axonal-stimulating single-fibre electromyography was performed in the extensor digitorum communis muscle of 23 patients with GBS, including 13 with the axonal form whose sera had a high titre of serum IgG anti-GM1 or -GD1a antibodies.
RESULTS:
All patients with axonal or demyelinating GBS showed normal or near-normal jitter, and no blocking.
CONCLUSION:
In both axonal and demyelinating GBS, neuromuscular transmission is not impaired. Our results failed to support the hypothesis that anti-GM1 or -GD1a antibody affects the NMJ. In GBS, impulse transmission is presumably impaired in the motor nerve terminal axons proximal to the NMJ.
AuthorsSatoshi Kuwabara, N Kokubun, S Misawa, K Kanai, S Isose, K Shibuya, Y Noto, M Mori, Y Sekiguchi, S Nasu, Y Fujimaki, K Hirata, N Yuki
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 82 Issue 10 Pg. 1174-7 (Oct 2011) ISSN: 1468-330X [Electronic] England
PMID21071752 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Immunoglobulin G
  • ganglioside GD1alpha
  • G(M1) Ganglioside
Topics
  • Adult
  • Aged
  • Autoantibodies (blood)
  • Axons (physiology)
  • Electromyography
  • Female
  • G(M1) Ganglioside (analogs & derivatives, immunology)
  • Guillain-Barre Syndrome (diagnosis, physiopathology)
  • Humans
  • Immunoglobulin G (blood)
  • Male
  • Middle Aged
  • Muscle, Skeletal (innervation)
  • Neuromuscular Junction (physiopathology)
  • Synaptic Transmission (physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: